UNIVO Pharmaceuticals ( (0 0%) ) is a vertically-integrated medical cannabis company covering all aspects of cultivation, manufacturing and distribution, Our highly experienced researchers holding PhDs in chemistry, analytical chemistry, biomedicine and pharmaceuticals come together to create innovative and dosage formed products for next-generation medical cannabis.
UNIVO possess licenses for the entire supply chain:
UNIVO produces its own cannabis by way of a partnership with Amit Farms, located in the South of Israel covering over 75,000m² with 15,000 m² designated for cannabis growth. The farm uses state-of-the art innovative agricultural technologies to grow high quality Cannabis and develop our own strains targeted to meet specific therapeutic needs.
Our UNIVO IMC-GMP manufacturing facility produces a wide variety of medical cannabis products that meet the most stringent international standards. The plant is IMC-GMP certified and began production in Q3 2019. UNIVO uses state-of-the-art Ethanol and CO2 based extraction technologies to manufacture a wide range of Medical Cannabis products. Additional technologies will be added to enable a different delivery systems and dosages to meet the needs of the products in our R&D pipeline.
Packaging and distribution of products is controlled and regulated from our factory which too is GDP+GSP certified.
UNIVO’s world class R&D guarantees a steady flow of new products in multiple doses with cutting edge dosage forms. Our team includes leading pharmacists, chemists, formulation specialists and Cannabis industry experts.
The UNIVO manufacturing facility is designed to safely store all finished products according to the strictest regulatory and security requirements. The UNIVO in-house distribution team works closely with our partners and customers to ensure the fast and safe delivery of our products.